AstraZeneca Research Collaboration Meeting

  • David Waugh (Participant)

Activity: Other activity typesHosting a delegation or group


Invited participant to advise and run the clinical development of CXCR2 inhibitors in castrate-resistant prostate cancer through academic consortia with Prof Johann de Bono (Royal Marsden Hospital) and Prof Alessandro Alimonti (Lugano, Switzerland). Teleconferences will agree trial protocol, external funding, patient recruitment etc.
Period17 Sept 2015
Held atAstraZeneca, Cambridge, United Kingdom